Factor XIII and the clotting of fibrinogen
The benefits of excess EPCR
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin
The significance of distal vein thrombosis and bilateral disease
Site and clinical outcome of deep vein thrombosis of the lower limbs
Changes in the technology of inferior vena cava filters promise improved benefits to the patient with less harm, but a paucity of evidence exists
Clinical experience with retrievable vena cava filters
Focal cerebral ischemia and hemostasis
Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice
Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor
Spatial and temporal dynamics of the endothelium
Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V
Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty – a prospective randomized double-blind placebo-controlled study
Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiency
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
The specific thromboxane receptor antagonist S18886
Molecular genetics of hereditary prothrombin deficiency in Indian patients
Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women
The first ambulatory screening on thromboembolism
HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait
The plasma hemostatic proteome
Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T→G factor X gene mutations are responsible for congenital factor X deficiency in patients of Nepali and Indian origin
Determinants of the APTT- and ETP-based APC sensitivity tests
Obesity enhances the induction of plasminogen activator inhibitor-1 by restraint stress
TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease
Platelet glycoprotein Ibα and integrin α2β1 polymorphisms
Association of polymorphisms of platelet membrane integrins αIIbβ3 (HPA-1b/PlA2) and α2β1 (α2807TT) with premature myocardial infarction
Stability of full-length recombinant FVIII formulated with sucrose during continuous infusion using a mini-pump infusion device
The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin
A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance
Genetic variation at the estrogen receptor α locus in relation to venous thromboembolism risk among postmenopausal women
Scanning electron microscopical observations of two novel hemostatic polymers
Long-haul flights do not activate hemostasis in young healthy men
Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy
A reconsideration of the evidence for structural reorganization in FVII zymogen
Vitamin D analogs down-regulate plasminogen activator inhibitor-1 in human coronary artery smooth muscle cells
More on
More on
More on
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients